Skip to content
1887

Abstract

The incidence of gonorrhoea has increased significantly in Norway over the past 10 years. The emergence of antimicrobial resistance and potential for increased rates of future treatment failure make epidemiological surveillance of a top priority. Here, we combine epidemiological data and genomic analyses of isolates from cases in Norway between January 2016 and May 2023 to identify genomic clusters and antimicrobial resistance patterns. We describe how the epidemiology of has changed before and after the COVID-19 pandemic and the lockdown restrictions of the Norwegian society. A total of 4,096 isolates, representing 39% of all the cases recorded by the Norwegian Surveillance System for Communicable Diseases, were analysed by whole-genome sequencing. Forty-one clusters, 12 of which encompassed more than 100 isolates, were identified. As seen in other countries, the lockdown of society in 2020–2021 led to a dramatic reduction in the cases of gonorrhoea. With the lifting of the restrictions, one cluster, dominated by sequence type 1580, rapidly expanded among young, heterosexual men and women. A significant increase in the fraction of female patients was observed through the study period. An increase in isolates resistant to azithromycin was observed throughout the study period, while the proportion of ciprofloxacin and cefixime resistance remained stable. A single ceftriaxone-resistant isolate was identified.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001479
2025-09-11
2025-11-08

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/mgen/11/9/mgen001479.html?itemId=/content/journal/mgen/10.1099/mgen.0.001479&mimeType=html&fmt=ahah

References

  1. NIPH Smittevernhåndboka - Gonoré – håndbok for helsepersonell; 2023 https://www.fhi.no/sm/smittevernhandboka/ ‌sykdommer-a-a/gonore/?term=#forekomst-i-norge
  2. Alfsnes K, Eldholm V, Olsen AO, Brynildsrud OB, Bohlin J et al. Genomic epidemiology and population structure of Neisseria gonorrhoeae in Norway, 2016-2017. Microb Genom 2020; 6:e000359 [View Article] [PubMed]
    [Google Scholar]
  3. MSIS Meldingssystem for smittsomme sykdommer (MSIS), Norwegian Surveillance System for Communicable Diseases; 2023 https://msis.no/
  4. Shaw D, Abad R, Amin-Chowdhury Z, Bautista A, Bennett D et al. Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium. Lancet Digit Health 2023; 5:e582–e593 [View Article] [PubMed]
    [Google Scholar]
  5. Ivarsson L, de Arriba Sánchez de la Campa M, Elfving K, Yin H, Gullsby K et al. Changes in testing and incidence of Chlamydia trachomatis and Neisseria gonorrhoeae – the possible impact of the COVID-19 pandemic in the three Scandinavian countries. Infectious Diseases 2022; 54:623–631 [View Article]
    [Google Scholar]
  6. Beauté J, Cowan S, Hiltunen-Back E, Kløvstad H, Velicko I et al. Travel-associated gonorrhoea in four Nordic countries, 2008 to 2013. Euro Surveill 2017; 22:30537 [View Article] [PubMed]
    [Google Scholar]
  7. Sánchez-Busó L, Cole MJ, Spiteri G, Day M, Jacobsson S et al. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. Lancet Microbe 2022; 3:e452–e463 [View Article] [PubMed]
    [Google Scholar]
  8. Osnes MN, Didelot X, Korne-Elenbaas J de, Alfsnes K, Brynildsrud OB et al. Sudden emergence of a Neisseria gonorrhoeae clade with reduced susceptibility to extended-spectrum cephalosporins, Norway. Microb Genom 2020; 6:e000480 [View Article] [PubMed]
    [Google Scholar]
  9. de Korne-Elenbaas J, Bruisten SM, de Vries HJC, Van Dam AP. Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis. J Antimicrob Chemother 2021; 76:1759–1768 [View Article] [PubMed]
    [Google Scholar]
  10. van Hal SJ, Whiley DM, Le T, Ray S, Kundu RL et al. Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype. J Antimicrob Chemother 2023; 78:2203–2208 [View Article] [PubMed]
    [Google Scholar]
  11. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 2014; 30:2114–2120 [View Article] [PubMed]
    [Google Scholar]
  12. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article] [PubMed]
    [Google Scholar]
  13. Mikheenko A, Prjibelski A, Saveliev V, Antipov D, Gurevich A. Versatile genome assembly evaluation with QUAST-LG. Bioinformatics 2018; 34:i142–i150 [View Article] [PubMed]
    [Google Scholar]
  14. Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 2018; 3:124 [View Article] [PubMed]
    [Google Scholar]
  15. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403–410 [View Article] [PubMed]
    [Google Scholar]
  16. Larsson A. AliView: a fast and lightweight alignment viewer and editor for large datasets. Bioinformatics 2014; 30:3276–3278 [View Article] [PubMed]
    [Google Scholar]
  17. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25:1754–1760 [View Article] [PubMed]
    [Google Scholar]
  18. Treangen TJ, Ondov BD, Koren S, Phillippy AM. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol 2014; 15:524 [View Article] [PubMed]
    [Google Scholar]
  19. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res 2015; 43:e15 [View Article] [PubMed]
    [Google Scholar]
  20. Tonkin-Hill G, Lees JA, Bentley SD, Frost SDW, Corander J. Fast hierarchical Bayesian analysis of population structure. Nucleic Acids Res 2019; 47:5539 [View Article] [PubMed]
    [Google Scholar]
  21. Didelot X, Croucher NJ, Bentley SD, Harris SR, Wilson DJ. Bayesian inference of ancestral dates on bacterial phylogenetic trees. Nucleic Acids Res 2018; 46:e134 [View Article] [PubMed]
    [Google Scholar]
  22. Zuckerkandl E. Molecular disease, evolution, and genic heterogeneity. In Horizons in Biochemistry 1962 pp 189–225
    [Google Scholar]
  23. Drummond AJ, Ho SYW, Phillips MJ, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol 2006; 4:e88 [View Article] [PubMed]
    [Google Scholar]
  24. Didelot X, Siveroni I, Volz EM. Additive Uncorrelated Relaxed Clock Models for the Dating of Genomic Epidemiology Phylogenies. Mol Biol Evol 2021; 38:307–317 [View Article] [PubMed]
    [Google Scholar]
  25. Volz EM, Frost SDW. Scalable relaxed clock phylogenetic dating. Virus Evol 2017; 3:vex025 [View Article]
    [Google Scholar]
  26. Volz EM, Didelot X. Modeling the growth and decline of pathogen effective population size provides insight into epidemic dynamics and drivers of antimicrobial resistance. Syst Biol 2018; 67:719–728 [View Article] [PubMed]
    [Google Scholar]
  27. Nei M, Li W-H. Mathematical model for studying genetic variation in terms of restriction endonucleases. Proc Natl Acad Sci USA 1979; 76:5269–5273 [View Article]
    [Google Scholar]
  28. Watterson GA. On the number of segregating sites in genetical models without recombination. Theor Popul Biol 1975; 7:256–276 [View Article] [PubMed]
    [Google Scholar]
  29. Sánchez-Busó L, Golparian D, Corander J, Grad YH, Ohnishi M et al. The impact of antimicrobials on gonococcal evolution. Nat Microbiol 2019; 4:1941–1950 [View Article] [PubMed]
    [Google Scholar]
  30. Fountain H, Migchelsen SJ, Charles H, Ram T, Fifer H et al. Rebound of Gonorrhea after Lifting of COVID-19 Preventive Measures, England. Emerg Infect Dis 2024; 30:329 [View Article]
    [Google Scholar]
  31. Pedersen TR, Wessman M, Lindegaard M, Hallstrøm S, Westergaard C et al. Gonorrhoea on the rise in Denmark since 2022: distinct clones drive increase in heterosexual individuals. Euro Surveill 2024; 29:2400059 [View Article] [PubMed]
    [Google Scholar]
  32. Zondag HCA, de Korne-Elenbaas J, Bruisten SM, de Vries HJC, van Dam AP. Increased clonality among Neisseria gonorrhoeae isolates during the COVID-19 pandemic in Amsterdam, the Netherlands. Microb Genom 2023; 9:000975 [View Article] [PubMed]
    [Google Scholar]
  33. Taouk ML, Taiaroa G, Duchene S, Low SJ, Higgs CK et al. Longitudinal genomic analysis of Neisseria gonorrhoeae transmission dynamics in Australia. Nat Commun 2024; 15:8076 [View Article] [PubMed]
    [Google Scholar]
  34. Fu Y-X, Li W-H. Statistical tests of neutrality of mutations. Genetics 1993; 133:693–709 [View Article] [PubMed]
    [Google Scholar]
  35. Tajima F. The effect of change in population size on DNA polymorphism. Genetics 1989a; 123:597–601 [View Article]
    [Google Scholar]
  36. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989b; 123:585–595 [View Article]
    [Google Scholar]
  37. Golparian D, Cole MJ, Sánchez-Busó L, Day M, Jacobsson S et al. Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study. Lancet Microbe 2024; 5:e478–e488 [View Article] [PubMed]
    [Google Scholar]
  38. Day MJ, Jacobsson S, Spiteri G, Kulishev C, Sajedi N et al. Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. BMC Infect Dis 2022; 22:524 [View Article] [PubMed]
    [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001479
Loading
/content/journal/mgen/10.1099/mgen.0.001479
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Supplementary material 2

PDF

Supplementary material 3

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error